# OnCo record paper-capp2-aspirin-lynch-syndrome-10-year-burn-lancet-2020 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-capp2-aspirin-lynch-syndrome-10-year-burn-lancet-2020/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-capp2-aspirin-lynch-syndrome-10-year-burn-lancet-2020" ;
  schema:name "CAPP2: cancer prevention with aspirin in Lynch syndrome, 10-year follow-up and registry-based 20-year data"@en ;
  schema:description "Ten years after two to four years of daily aspirin, people with Lynch syndrome had developed about a third fewer bowel cancers than those on placebo, confirming aspirin as a preventive treatment for the condition."@en ;
  schema:url <https://onco.cc/key-papers/paper-capp2-aspirin-lynch-syndrome-10-year-burn-lancet-2020/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0140-6736(20)30366-4>, <https://pubmed.ncbi.nlm.nih.gov/32534647/> ;
  schema:sameAs <https://doi.org/10.1016/S0140-6736(20)30366-4> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Burn J, Sheth H, Elliott F, et al." ;
  onco:cancers <https://onco.cc/cancers/msi-high-colorectal/> ;
  onco:drugs <https://onco.cc/drugs/aspirin/> ;
  onco:trials <https://onco.cc/trials/capp2/> ;
  onco:journals <https://onco.cc/journals/lancet/> .
